http://www.onemedplace.com/blog/wp-content/uploads/2009/09/biosante.jpg
On 9/22/09, BioSante and Cell Genesys (NASDAQ: CEGE) announced that they have determined the final exchange ratio will be 0.1828 in connection with the previously announced merger between the companies.
View Articlehttp://www.onemedplace.com/blog/wp-content/uploads/2010/05/hand_on_the_sky.jpg
Administering medication transdermally offers several advantages over other methods of drug delivery.
View Article
More Pages to Explore .....
